GLS and cancer: Although drug-target interactome could not show the full extent of transcription factors and signalling proteins affecting glutaminase, enrichment of many cancer signalling pathways (e.g., Ras, MAPK and JAK-STAT) underlines this strong interplay between glutaminase and these proteins and hereby associated with mitochondrial metabolism, immune response and cell proliferation.